1. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial. (1st June 2020) Authors: Blauvelt, A.; Papp, K.; Gottlieb, A.; Jarell, A.; Reich, K.; Maari, C.; Gordon, K.B.; Ferris, L.K.; Langley, R.G.; Tada, Y.; Lima, R.G.; Elmaraghy, H.; Gallo, G.; Renda, L.; Park, S.Y.; Burge, R.; Bagel, J.; Vender, Ronald; Lomaga, Mark A.; Delorme, Isabelle Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Manifestations of Pediatric Psoriasis: Results of a Multicenter Study in the United States. Issue 4 (30th January 2013) Authors: Mercy, Katherine; Kwasny, Mary; Cordoro, Kelly M.; Menter, Alan; Tom, Wynnis L.; Korman, Neil; Belazarian, Leah; Armstrong, April W.; Levy, Moise L.; Paller, Amy S. Journal: Pediatric dermatology Issue: Volume 30:Issue 4(2013) Page Start: 424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Paving the Way for Future Medical Dermatology Leaders in Psoriasis and Psoriatic Arthritis: 1st Annual Mentoring Program for Dermatology Fellows. Issue 3 (September 2013) Authors: Husni, M. Elaine; Duch, Daniel; Korman, Neil Journal: Psoriasis forum Issue: Volume 19a:Issue 3(2013) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗